Real time monitoring of COVID-19 intervention effectiveness through contact tracing data
- PMID: 37296143
- PMCID: PMC10250864
- DOI: 10.1038/s41598-023-35892-0
Real time monitoring of COVID-19 intervention effectiveness through contact tracing data
Abstract
Communities worldwide have used vaccines and facemasks to mitigate the COVID-19 pandemic. When an individual opts to vaccinate or wear a mask, they may lower their own risk of becoming infected as well as the risk that they pose to others while infected. The first benefit-reducing susceptibility-has been established across multiple studies, while the second-reducing infectivity-is less well understood. Using a new statistical method, we estimate the efficacy of vaccines and facemasks at reducing both types of risks from contact tracing data collected in an urban setting. We find that vaccination reduced the risk of onward transmission by 40.7% [95% CI 25.8-53.2%] during the Delta wave and 31.0% [95% CI 19.4-40.9%] during the Omicron wave and that mask wearing reduced the risk of infection by 64.2% [95% CI 5.8-77.3%] during the Omicron wave. By harnessing commonly-collected contact tracing data, the approach can broadly provide timely and actionable estimates of intervention efficacy against a rapidly evolving pathogen.
© 2023. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures



References
-
- Braeye T, Cornelissen L, Catteau L, Haarhuis F, Proesmans K, De Ridder K, Djiena A, Mahieu R, De Leeuw F, Dreuw A, Hammami N, Quoilin S, Van Oyen H, Wyndham-Thomas C, Van Cauteren D. Vaccine effectiveness against infection and onwards transmission of COVID-19: Analysis of belgian contact tracing data, January-June 2021. Vaccine. 2021;39(39):5456–5460. doi: 10.1016/j.vaccine.2021.08.060. - DOI - PMC - PubMed
-
- Oon TN, Vanessa K, Calvin JC, Kalisvar M, Natascha MT, Tze MM, Joon KC, Shannen SHO, Yong KL, Zannatul F, Alifa KBJ, Mark I-CC, Sebastian M-S, Lin C, Raymond TPL, Kelvin BT, Alex RC, Prof Y-SL, Vernon JL. Impact of delta variant and vaccination on SARS-CoV-2 secondary attack rate among household close contacts. Lancet Reg. Health West Pac. 2021;17:100299. doi: 10.1016/j.lanwpc.2021.100299. - DOI - PMC - PubMed
-
- Patrick T, Mohammad RH, Hiam C, Hadi MY, Fatiha MB, Hebah AAK, Sawsan A, Peter C, Houssein HA, Zaina AK, Einas AK, Andrew J, Anvar HK, Ali NL, Riyazuddin MS, Hanan FAR, Gheyath KN, Mohamed GAK, Hamad EAR, Adeel AB, Mohamed HA-T, Abdullatif AK, Roberto B, Laith JA-R. BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the SARS-CoV-2 delta variant in qatar. Nat. Med. 2021;5:968. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical